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Abstract
Background: Mixed results exist as to whether positive surgical margins impact survival. The aim
of this study was to determine whether positive surgical margins are indeed associated with
decreased survival in patients with primary head and neck cancer.
Methods: We conducted a retrospective cohort study of 261 cases diagnosed with cancer of the
larynx or tongue between 1995 and 1999. Cases were followed through December 31, 2002.
Survival curves by margin status were generated by Kaplan-Meier methods. Categorical data were
evaluated with odds ratios (OR).
Results: All-cause mortality was markedly higher in cases with positive margins as compared with
those with negative margins (54% versus 29%, P = 0.005). This pattern also appeared after adjusting
for age and sex (OR = 2.97, 95% CI: 1.29 – 6.84).
Conclusion: Our findings suggest that positive surgical margin status is associated with increased
mortality. This association also generally persists after adjustment for tumor size, stage, and
adjuvant therapy.
Background
Approximately 37,000 men and women in the U.S. were
diagnosed with head and neck cancers in 2003 [1]. In par-
ticular, individuals with tongue and larynx cancer
accounted for 45% of the head and neck cancer cases diag-
nosed. Such cancers are more frequently diagnosed
among men and in people over age 50. These cancers are
highly fatal, and mortality rates have not decreased signif-
icantly over time [1]. Based on recent national U.S. statis-
tics, the five-year survival is 64% for larynx cancer and
56% for cancer of the oral cavity [1,2]. The treatment plan
for an individual patient depends on a number of factors,
including the exact location of the tumor, the stage of the
cancer, and the person's age and general health status [3].
Patients with head and neck cancer are frequently treated
with surgery, with removal of the cancer including some
of the healthy tissue around it. Surgery may be followed
by radiation treatment. But, the side effects of aggressive
surgery and radiation can be devastating. Severe conse-
quences may include permanent loss of voice, swallowing
and speech problems, tongue and neck deformity and
scar, and paralysis of cranial nerves. Significant expertise is
needed to preserve healthy tissue to the extent possible to
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maintain these important functions while ensuring that
the cancer is removed.
Although obtaining negative surgical margins (i.e., cancer
was entirely removed) is the goal of the head and neck sur-
geon, achieving this may be impossible because of func-
tional consequences. Thus, some patients are left with
positive surgical margins (i.e., those in which residual
cancer cells remain) to preserve vital organs like the
carotid artery. Whether positive surgical margins impact
survival remains equivocal [4]. Positive surgical margins
are reported to be negatively associated with survival in
many, although not in all of the published studies [5,6].
Some studies did not find an association between positive
surgical margins and an increased risk of mortality; how-
ever, many of these studies included a small number of
patients, or the possibility existed that there was no
increase in mortality because patients with positive surgi-
cal margins received adjuvant radiation therapy [7,8]. In
addition, many of the prior studies did not attempt to
exclude cases with a known history of cancer, which may
impact survival. The objective of this study was to deter-
mine whether positive surgical margins are indeed associ-
ated with lower survival.
Methods
Design and setting
The study was a retrospective cohort of larynx and tongue
cancer cases diagnosed at Kaiser Permanente Southern
California (KPSC), a health maintenance organization of
11 medical centers with over three million members. The
study was reviewed and approved by the KPSC Institu-
tional Review Board.
Study patients
Study patients were identified through the health plan's
cancer registry. The KPSC cancer registry is a population-
based registry that reports to the American College of Sur-
geons' National Cancer Data Base and National Cancer
Institute's Surveillance Epidemiology and End Results
Program. Primary tongue and larynx cancer cases included
patients who were diagnosed between January 1, 1995
and December 31, 1999 who underwent surgical resec-
tion as the primary course of treatment, and were active
health plan members of KPSC on the date of surgery
(International Classification of Disease for Oncology
[ICD-O] Version 2 codes C01.9, C02.0–C02.4, C02.8,
C02.9, C32.0–C32.3, C32.8, C32.9). To minimize the
possibility of having biased survival times, we excluded
patients with a known history of cancer.
Cases with negative margins included patients with no
involvement of margins (i.e., reported free by the pathol-
ogist). Cases with positive margins were defined to be
those in whom residual cancer cells were found in the sur-
gical margin when tissue sections were examined with a
microscope (microscopically positive) or visible to the
unaided eye (grossly positive). These categories describe
the surgical margins status after resection of the primary
tumor as recorded by the pathologist.
Data collection
Variables abstracted from the cancer registry included age
at diagnosis, sex, ethnicity, ICD-O (International Classifi-
cation of Diseases, Oncology) diagnosis, diagnosis date,
TNM stage (tumor, node, metastases), surgery date, surgi-
cal margin status, radiation therapy, vital status, and cause
of death.
Vital status was ascertained by using a combination of
research and automated databases. Deaths were identified
through the California's master file of death certificates,
inpatient hospital files, the cancer registry, and the
National Death Index. Because cause of death informa-
tion was missing for over 90% of the patients in these
automated databases, we used all-cause mortality as the
endpoint.
We classified patients as being alive at end of study if they
had any one of the following after December 31, 2002: 1)
an outpatient doctor visit; 2) an inpatient hospitalization;
or 3) received a pharmacy prescription. Because these
patients have a highly fatal cancer requiring medical care,
they would appear in one of these databases.
Statistical analysis
The statistical significance of differences for categorical
data was evaluated using chi-square or Fisher's exact test.
Odds ratios (OR) were used to estimate the size of associ-
ations; ORs were adjusted for age and sex, and stratified by
tumor characteristics and surgical treatment separately.
For the survival analysis, patients were followed from the
date of surgery to December 31, 2002. We examined over-
all survival defined as the interval between the date of sur-
gery and December 31, 2002 or the date of death due to
any cause, whichever occurred first. Survival time was cen-
sored if a patient lived past the end of follow-up. Survival
curves by margin status were generated by Kaplan-Meier
methods. Differences in survival between cases with posi-
tive and negative margins were evaluated using the log-
rank test. All analyses were conducted with SAS Version 8
[9].
Results
We identified 261 newly diagnosed cases through the
health plan's cancer registry (51% with tongue cancer and
49% with larynx cancer). The number of cases diagnosed
by year was relatively constant after 1995 (Table 1). More
men were diagnosed with these cancers compared to
females (71% versus 30%). The number of cases increasedBMC Ear, Nose and Throat Disorders 2006, 6:2 http://www.biomedcentral.com/1472-6815/6/2
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with age, with the majority of patients diagnosed between
ages 60 and 69 (37%). Over 75% of the patients were
white. Over 90% of the 261 total study patients had squa-
mos cell carcinoma.
A total of 233 patients had negative margins and 28 had
positive margins (Table 2). Cases with negative margins
were more likely to have tumors ≤2 cm in size, whereas
those with positive margins had larger tumors (>2 cm).
However, tumor size data was missing for over 30% of the
cases. Although a 2 cm tumor for laryngeal cancer may be
considered large, we found only two patients exist with
laryngeal cancer who had <2 cm size margins and positive
margins, thus making it impracticable to conduct analyses
stratified by lower cut-off points. The majority of cases
with negative margins presented with TNM stage 0 or I
disease. In contrast, patients with positive margins were
more likely to present with TNM stage IV disease and
undergo adjuvant radiotherapy (P < 0.0001).
Among cases with large tumors (>2 cm), mortality was
dramatically greater in cases with positive margins as
compared to those with negative margins (OR, 2.47, 95%
CI: 0.69–8.91, Table 3). A similar association was not seen
among those with smaller tumors (<2 cm); however, the
number of individuals with positive margins was too
small to draw an inference. We also examined the associ-
ation by TNM stage. Because of the small number of
patients with stage 0 disease, we combined this category
with stages I to III in the analyses to allow for the calcula-
tion of the ORs. Mortality was over three-fold greater in
cases with positive margins among those diagnosed with
stage 0 to III disease (OR = 3.32, 95% CI: 0.92 – 11.99).
There was no difference in mortality by surgical margins
status when examining cases diagnosed with stage IV dis-
ease (OR = 1.07, 95% CI: 0.35 – 3.29) but the confidence
interval was wide. Adjustment for age and sex did not
affect the associations.
Overall mortality was nearly three-fold greater in cases
with positive margins as compared to those with negative
margins (age-sex adjusted, OR = 2.97, 95% CI: 1.29 –
6.84, Table 4). Similar associations were seen among
patients who underwent surgery only (154 cases) and
among those treated with adjuvant radiotherapy (107
cases), although confidence intervals were again wide.
In the survival analysis, cases were followed a maximum
of 8 years (range of 2.5 to 96 months). We observed 82
deaths during the study period. The overall survival prob-
ability was 31%. All-cause mortality was markedly higher
in cases with positive margins as compared with those
with negative margins (54% versus 29%, P = 0.005, Table
4 and Figure 1).
Cause of death was not available in the various electronic
files. We found cause of death for only 25 individuals. Of
these 25 patients, 15 (60%) died from a malignant neo-
plasm of the head or neck; 5 (20%) due to cardiovascular
disease; and 5 (20%) died due to pneumonia or other
causes.
Discussion
We examined the association between surgical margin sta-
tus and survival using a cohort of 261 patients diagnosed
from 1995 to 1999, with some patients followed five or
more years. All-cause mortality was markedly higher in
cases with positive margins as compared with those with
negative margins (54% versus 29%) during the eight year
study period. The age and sex adjusted OR suggests that
positive surgical margin status is associated with nearly a
three-fold increased risk of mortality (2.97, 95% CI: 1.29
– 6.84). This association appears to generally persist even
after adjustment type of treatment (surgery alone or with
adjuvant radiation therapy), among cases with large
tumors (>2 cm), and those with TNM stage 0 to III disease
at diagnosis; however, these analyses were based on small
numbers of cases. These findings are consistent with the
few reports that specifically examined the effect of surgical
margins on survival of head and neck cancer [4,5,10,11].
Other studies did not find a clear association between
positive surgical margins and an increased risk of death,
Table 1: Demographic characteristics of incident tongue and 
larynx cancer cases
N (N = 261) %
Year of diagnoses
1995 48 18.4
1996 54 20.7
1997 58 22.2
1998 52 19.9
1999 49 18.8
Gender
Male 185 70.9
Female 76 29.1
Age at diagnosis
<40 11 4.2
40–49 33 12.6
50–59 66 25.3
60–69 96 36.8
70+ 55 21.1
Ethnicity
White 202 77.4
Black 24 9.2
Asian 16 6.1
Hispanic 16 6.1
Other/Unknown 3 1.2BMC Ear, Nose and Throat Disorders 2006, 6:2 http://www.biomedcentral.com/1472-6815/6/2
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possibly due to even smaller sample sizes to detect a dif-
ference (e.g. [7]), or did not specifically examine the effect
of margins on survival.
Use of all-cause mortality is a potential limitation. We
examined all cause mortality because cause of death infor-
mation was available for only 25 cases who died. Using
all-cause mortality would underestimate mortality due to
cancer, but it is unlikely to lead to bias in estimation of the
relationship of margins with survival since death due to
causes other than cancer is unlikely to be related to margin
status. In addition, we did not have information on chem-
otherapy in patients who might have experienced subse-
quent metastases. Indication for adjuvant therapy such as
chemotherapy and radiotherapy would have entailed
patient chart review which was beyond the scope of this
study. Another potential limitation is was the lack of elec-
tronic data on the sub-anatomic sites of the tongue to
examine the association between margin status and mor-
tality. For example, it is more complicated to obtain neg-
ative margins for the base of tongue tumors. Although the
present study includes one of the largest series investi-
Table 2: Tumor characteristics by margin status in incident tongue and larynx cancer cases
Negative Margins (N = 233) Positive Margins (N = 28) P*
N%N%
Tongue
Tumor size (cm)
≤ 26 0 4 9 . 5 6 4 6 . 2
>2 cm 34 28.2 5 38.5
Missing 27 22.3 2 15.4
TNM Stage
0 – I 66 54.5 2 15.4
II 22 18.2 2 15.4
III 17 14.1 2 15.4
IV 14 11.6 7 53.8
Missing 2 1.7 0 --
Larynx
Tumor size (cm)
≤ 22 3 2 0 . 5 2 1 3 . 3
>2 cm 42 37.5 7 46.7
Missing 47 42.0 6 40.0
TNM Stage
0 – I 44 39.2 3 20.0
II 12 10.7 1 6.7
III 29 25.9 0 --
IV 25 22.3 11 73.3
Missing 2 1.8 0 --
Overall
Primary site
Tongue 121 51.9 13 46.4
Larynx 112 48.1 15 53.6
Tumor size (cm)
≤ 2 83 35.6 8 28.5 0.575
>2 cm 76 32.6 12 42.8
Missing 74 31.7 8 28.5
TNM Stage
0 – I 110 47.2 5 17.8 <0.0001
II 34 14.6 3 10.7
III 46 19.7 2 0.7
IV 39 16.7 18 64.2
Missing 4 0.2 0 0
*P value based on chi-square distribution. Not calculated for the individual primary sites due to small cell size.BMC Ear, Nose and Throat Disorders 2006, 6:2 http://www.biomedcentral.com/1472-6815/6/2
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gated, the study only included 28 patients with positive
surgical margins. Therefore, in the analyses we examined
overall survival for the two primary sites combined that
would be based on more stable estimates.
A major strength of the study is that it includes a large
population-based cohort, which is more likely to be rep-
resentative of all individuals who develop cancer of
tongue and larynx than studies from academic specialty
centers. Virtually all previous studies we identified were
based on patients from academic specialty centers who
might have been more likely to have more aggressive
forms of the disease [4-12]. Another strength is that our
study involved patients who were diagnosed over a five-
year time frame, during which surgical and treatment
modalities were unlikely to vary substantially. Some pre-
vious studies included patients who diagnosed over dec-
ades. Further, our study excluded patients with a known
history of cancer. All patients receive all their health care
within this integrated HMO; therefore, the study included
virtually every case diagnosed and treated during the study
period.
Conclusion
Cancers of larynx and tongue are aggressive and prognosis
is poor. Surgery has been the primary course of treatment
for these diseases. Our results suggest that positive surgical
margin status is associated with decreased survival. How-
ever, achieving negative margins can cause impairment in
important functions such as chewing, swallowing and
speech, and adversely affect quality of life. Measures of
quality of life are not available in the health plans elec-
tronic databases, and ascertaining such information was
beyond the scope of the present study. Detailed prospec-
tive data collection would be needed to understand the
functional limitations experienced by patients with nega-
tive and positive margins. The appropriate balance
between quality and quantity of life remains a difficult
clinical decision.
Table 4: Association between surgical margins and mortality by surgical treatment in cases with tongue or larynx cancer
Therapy Died (N) Alive (N) Mortality (%) Odds Ratio (95% CI) Age-sex adjusted OR (95% CI)
All cases
Positive 15 13 53.6 2.85 (1.19 – 6.89) 2.97 (1.29 – 6.84)
Negative 67 166 28.8
Surgery only
Positive 3 4 42.9 2.38 (0.33 – 14.85) 2.20 (0.42 – 11.55)
Negative 35 112 23.8
Surgery + adjuvant 
radiotherapy
Positive 12 9 57.1 2.23 (0.77 – 6.74) 1.98 (0.68 – 5.84)
Negative 32 54 37.2
Table 3: Association between surgical margins and mortality by tumor characteristics
Therapy Died (N) Alive (N) Odds Ratio (95% CI) Age-sex adjusted OR (95% CI)
Tumor size
≤ 2 cm
Positive 7 1 0.45 (0.05 – 3.89) 0.41 (0.04 – 4.05)
Negative 63 20
> 2 cm
Positive 4 8 2.47 (0.69 – 8.91) 2.37 (0.58 – 9.75)
Negative 42 34
TNM Stage
0 – III
Positive 5 5 3.32 (0.92 – 11.99) 3.34 (0.86 – 13.07)
Negative 146 44
IV
Positive 8 10 1.07 (0.35 – 3.29) 0.95 (0.26 – 3.51)
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